Effectiveness of Percutaneous Pulley Release With Infiltration, Versus Infiltration Alone in Trigger Finders
- Disease/Condition
- Trigger Finger
- Drug/Device/Intervention
- Percutaneous A1 Pulley Release Under Ultrasound Guidance
- Study type
- Interventional
- Intervention type
- procedure
- Primary sponsor
- Centre Hospitalier Departemental Vendee
- Location
- Créteil,La Roche Sur Yon 9,Nantes,Paris, France
- Phase
- N/A
- Start date
- Mar 31, 2022
- End date
- Nov 30, 2025
- Enrollment
- 90 participants
Effectiveness of pulley section with ultrasound guidance combined with corticosteroid infiltration versus corticosteroid alone on complete resolution of trigger finger's symptoms
Trigger finger is a mechanical problem characterized by pain and catching of digit in
 flexion.
 
 Histological changes of A1 pulley and synovial proliferation have been identified as factors
 that prompt trigger finger The first-line treatment of trigger finger is conservative with
 splinting and corticosteroid injection.
 
 If the first infiltration fails, either a second infiltration or surgical sectioning of the
 pulley is proposed.
 
 Surgery can be performed by several techniques (open section, percutaneous section with
 palpatory guidance, or under ultrasound guidance).
 
 Percutaneous A1 pulley release under ultrasound guidance consists of cutting the A1 pulley by
 a percutaneous insertion with small needle under local anaesthesia.
 
 The hypothesis of the study is that percutaneous A1 pulley release under ultrasound guidance
 followed by a corticosteroid injection would be more effective than a second corticosteroid
 injection alone on complete resolution of the trigger finger symptoms
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT05045157
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT05045157 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Departemental Vendee and is currently Not yet recruiting. The study focuses on Trigger Finger. Target enrollment is 90 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.